Literature DB >> 9874717

Pharmacokinetics and organ distribution of cationized colchicine-specific IgG and Fab fragments in rat.

G Hong1, M I Bazin-Redureau, J M Scherrmann.   

Abstract

Pharmacokinetics of cationized goat colchicine-specific polyclonal immunoglobulin G (IgG) and antigen binding fragment (Fab) (cIgG and cFab, respectively) were studied in male adult Sprague-Dawley rats and compared with those of the native proteins (nIgG and nFab). All proteins were radioiodinated by the Iodogen method, and kinetics were investigated following trichloroacetic acid (TCA) precipitation or immunoprecipitation. Deiodination and catabolism were more pronounced with the cationized than the native proteins, especially for cFab. Both cIgG and cFab in plasma decreased more rapidly than nIgG and nFab. The elimination half-lives were 52.9 and 81.8 h for cIgG and nIgG, respectively. In addition, there was a 74-fold increase in the volume of distribution and a 114-fold increase in the systemic clearance of cIgG compared with nIgG. For cFab, the volume of distribution and systemic clearance were increased 6.4- and 3.5-fold, respectively. Organ uptake of cIgG and cFab was markedly increased compared with that of nIgG and nFab, especially in kidney, liver, spleen, and lung. Renal clearance of cIgG and cFab was also increased 30- and 10-fold compared with that of nIgG and nFab, respectively. The present data suggest that cationization of colchicine-specific IgG and Fab fragments increased the organ distribution and greatly altered their pharmacokinetics. Nevertheless, the smaller molecular size of Fab versus IgG did not enhance the distribution and clearance of cFab. These data pave the way for evaluating the biological efficacy of these more tissue-organ-interactive antibodies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9874717     DOI: 10.1021/js970335n

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges.

Authors:  Yulia Vugmeyster; Xin Xu; Frank-Peter Theil; Leslie A Khawli; Michael W Leach
Journal:  World J Biol Chem       Date:  2012-04-26

Review 2.  Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies.

Authors:  Yi Du; Alison Walsh; Robin Ehrick; Wei Xu; Kimberly May; Hongcheng Liu
Journal:  MAbs       Date:  2012-07-23       Impact factor: 5.857

3.  Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats.

Authors:  Leslie A Khawli; Sirj Goswami; Ryan Hutchinson; Zephania W Kwong; Jihong Yang; Xiangdan Wang; Zhenling Yao; Alavattam Sreedhara; Tony Cano; Devin Tesar; Ihsan Nijem; David E Allison; Pin Yee Wong; Yung-Hsiang Kao; Cynthia Quan; Amita Joshi; Reed J Harris; Paul Motchnik
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

4.  Minimal Physiologically-based Pharmacokinetic Model to Investigate the Effect of Charge on the Pharmacokinetics of Humanized anti-HCV-E2 IgG Antibodies in Sprague-Dawley Rats.

Authors:  Deni Hardiansyah; Chee Meng Ng
Journal:  Pharm Res       Date:  2022-03-04       Impact factor: 4.200

5.  Efficacy, Pharmacokinetics, Biodistribution and Excretion of a Novel Acylated Long-Acting Insulin Analogue INS061 in Rats.

Authors:  Kai Pan; Xiaolei Shi; Kai Liu; Ju Wang; Yijun Chen
Journal:  Drug Des Devel Ther       Date:  2021-08-10       Impact factor: 4.162

6.  Examining cellular responses to reconstituted antibody protein liquids.

Authors:  M Tyler Nelson; Joseph M Slocik; Eric J Romer; Cassandra I Mankus; Richard T Agans; Rajesh R Naik; Saber M Hussain
Journal:  Sci Rep       Date:  2021-08-23       Impact factor: 4.996

7.  Comparative analytical profiling of bevacizumab biosimilars marketed in India: a national control laboratory study.

Authors:  Anu Prakash; Nripendra N Mishra; Utpreksha Vaish; Sonia Sharma; Apoorva Anand; Richi V Mahajan; J P Prasad; Subhash Chand
Journal:  3 Biotech       Date:  2020-11-09       Impact factor: 2.406

Review 8.  Protein comparability assessments and potential applicability of high throughput biophysical methods and data visualization tools to compare physical stability profiles.

Authors:  Mohammad A Alsenaidy; Nishant K Jain; Jae H Kim; C Russell Middaugh; David B Volkin
Journal:  Front Pharmacol       Date:  2014-03-12       Impact factor: 5.810

9.  Charge Variants of an Avastin Biosimilar Isolation, Characterization, In Vitro Properties and Pharmacokinetics in Rat.

Authors:  Yan-Yan Zhao; Ning Wang; Wan-Hui Liu; Wen-Jie Tao; Li-Li Liu; Zhen-Duo Shen
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

Review 10.  Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development.

Authors:  Jay Tibbitts; David Canter; Ryan Graff; Alison Smith; Leslie A Khawli
Journal:  MAbs       Date:  2015-12-04       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.